Fiorino Claudio, Alongi Filippo, Broggi Sara, Cattaneo Giovanni Mauro, Cozzarini Cesare, Di Muzio Nadia, Maggiulli Eleonora, Mangili Paola, Perna Lucia, Valdagni Riccardo, Fazio Ferruccio, Calandrino Riccardo
Medical Physics, S. Raffaele Institute, Milano, Italy.
Acta Oncol. 2008;47(7):1309-16. doi: 10.1080/02841860802266755.
To review planning and image-guidance aspects of more than 3 years experience in the treatment of prostate cancer with Helical Tomotherapy (HT).
Planning issues concerning two Phase I-II clinical studies were addressed: in the first one, 58 Gy in 20 fractions were delivered to the prostatic bed for post-prostatectomy patients: in the second one, a simultaneous integrated boost (SIB) approach was applied for radical treatment, delivering 71.4-74.2 Gy to the prostate in 28 fractions. On-line daily MVCT image guidance was applied: bone match was used for post-operative patients while prostate match was applied for radically treated patients. MVCT data of a large sample of both categories of patients were reviewed.
At now, more than 250 patients were treated. Planning data show the ability of HT in creating highly homogeneous dose distributions within PTVs. Organs at risk (OAR) sparing also showed to be excellent. HT was also found to favorably compare to inversely-optimized IMAT in terms of PTVs coverage and dose distribution homogeneity. In the case of pelvic nodes irradiation, a large sparing of bowel was evident compared to 3DCRT and conventional 5-fields IMRT. The analysis of MVCT data showed a limited motion of the prostate (about 5% of the fractions show a deviation > or =3 mm in posterior-anterior direction), due to the careful application of rectal emptying procedures. Based on phantom measurements and on the comparison with intra-prostatic calcification-based match, direct visualization prostate match seems to be sufficiently reliable in assessing shifts > or =3 mm.
HT offers excellent planning solutions for prostate cancer, showing to be highly efficient in a SIB scenario. Daily MVCT information showed evidence of a limited motion of the prostate in the context of rectal filling control obtained by instructing patients in self-administrating a rectal enema.
回顾超过3年使用螺旋断层放射治疗(HT)治疗前列腺癌的计划制定及图像引导方面的经验。
探讨了两项I-II期临床研究的计划制定问题:第一项研究中,对前列腺切除术后患者的前列腺床给予20次分割、总量58 Gy的照射;第二项研究中,采用同步整合加量(SIB)方法进行根治性治疗,28次分割给予前列腺71.4 - 74.2 Gy的照射。采用在线每日兆伏级计算机断层扫描(MVCT)图像引导:术后患者使用骨匹配,根治性治疗患者使用前列腺匹配。回顾了这两类患者大量样本的MVCT数据。
目前已治疗250多名患者。计划数据显示HT能够在计划靶体积(PTV)内创建高度均匀的剂量分布。危及器官(OAR)的保护也非常出色。在PTV覆盖和剂量分布均匀性方面,HT与逆向优化的容积调强弧形治疗(IMAT)相比也具有优势。在盆腔淋巴结照射的情况下,与三维适形放疗(3DCRT)和传统五野调强放疗(IMRT)相比,肠道的受量明显减少。MVCT数据分析显示前列腺运动有限(约5%的分次在前后方向上偏差≥3 mm),这归因于直肠排空程序的精心应用。基于模体测量以及与基于前列腺内钙化的匹配进行比较,直接可视化前列腺匹配在评估≥3 mm的移位时似乎足够可靠。
HT为前列腺癌提供了出色的计划解决方案,在SIB方案中显示出高效性。每日MVCT信息表明,通过指导患者自行灌肠控制直肠充盈,前列腺运动有限。